Compliance Insight Podcasts: Implementing Process Validation - Episode 2
Step-by-Step Validation for Bio/Pharmaceuticals: Meeting New Regulatory Expectations
Implementing Process Validation - Episode 2
Listeners will learn the differences between traditional process validation and new regulatory expectations under the 2011 FDA Process Validation guidance, including how to implement changes to meet a life-cycle approach, what tools can best monitor and assess performance, and how to perform qualification as well as verification under the new guidance. Unique differences between US and European validation guidelines are also discussed.
Compliance Insight podcast Series>>
Add this Podcast feed to your media player
Sponsored By:
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
